Literature DB >> 20610861

Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production.

D D Smith1, X Tan, O Tawfik, G Milne, D J Stechschulte, K N Dileepan.   

Abstract

The production of thromboxane A(2) (TXA(2)) and prostacyclin (prostaglandin I(2), PGI(2)) is known to be increased in patients with atherosclerosis. In this study, we evaluated the influence of gender on TXA(2) and PGI(2) production, and their association with the progression of atherosclerosis in apolipoprotein E-null (ApoE(-/-)) mice maintained on a high fat diet for 3 months. En face analyses of aortas showed marked increases in plaque formation in female ApoE(-/-) mice. Quantification of the hematoxylin/eosin (H&E) stained cross sections of the aortic arch revealed 3 to 4-fold higher plaque thickness in female ApoE(-/-) mice. Analyses of 24-hours urine samples for 11-dehydro TXB(2) and 2, 3-dinor-6-keto PGF(1a) indicated that female ApoE(-/-) mice produce up to 15-fold more TXA(2) and 50% less PGI(2) than the age matched males. Interestingly, the serum cholesterol levels in ApoE(-/-) females were 20% lower than males on the high fat regimen. No gender-associated changes in the number of T lymphocytes, mast cells and macrophages were evident in the lesion areas of ApoE(-/-) mice. The results suggest that the markedly elevated TXA(2) production and reduced PGI(2) production are gender-related proatherogenic risk factors in female ApoE(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610861      PMCID: PMC3515053     

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  51 in total

1.  Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice.

Authors:  M M Marsh; V R Walker; L K Curtiss; C L Banka
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

2.  Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.

Authors:  D Praticò; T Cyrus; H Li; G A FitzGerald
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

3.  Effect of antiestrogen regimen on prostacyclin and thromboxane A2 in postmenopausal patients with breast cancer: evidence of significance of hypertension, smoking or previous use of estrogen therapy.

Authors:  M B Marttunen; S Pyrhönen; A E Tiitinen; L U Viinikka; O Ylikorkala
Journal:  Prostaglandins       Date:  1996-10

Review 4.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

Review 5.  Apoptosis in cardiovascular disease.

Authors:  M J Davies
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

6.  Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

Authors:  O Belton; D Byrne; D Kearney; A Leahy; D J Fitzgerald
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice.

Authors:  J Reckless; J C Metcalfe; D J Grainger
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

8.  Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors: 
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

9.  Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice.

Authors:  P A Bourassa; P M Milos; B J Gaynor; J L Breslow; R J Aiello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Transcriptomic analysis of aorta from a short-term high-fat diet fed mouse reveals changes in the expression of vessel structure genes.

Authors:  N Dejeans; S Auclair; S Chauvet; D Milenkovic; A Mazur
Journal:  J Physiol Pharmacol       Date:  2009-05       Impact factor: 3.011

View more
  27 in total

Review 1.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

Review 2.  Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors:  Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

Review 3.  Role of shear stress and stretch in vascular mechanobiology.

Authors:  Deshun Lu; Ghassan S Kassab
Journal:  J R Soc Interface       Date:  2011-07-06       Impact factor: 4.118

Review 4.  Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors:  Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

5.  Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice.

Authors:  Masa-Aki Shibata; Eiko Shibata; Kentaro Maemura; Yoichi Kondo; Mariko Harada-Shiba
Journal:  Med Mol Morphol       Date:  2017-02-28       Impact factor: 2.309

6.  Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice.

Authors:  Donald D Smith; Xiaoyu Tan; Vineesh V Raveendran; Ossama Tawfik; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-13       Impact factor: 4.733

7.  The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.

Authors:  Mafalda Cacciottolo; Amy Christensen; Alexandra Moser; Jiahui Liu; Christian J Pike; Conor Smith; Mary Jo LaDu; Patrick M Sullivan; Todd E Morgan; Egor Dolzhenko; Andreas Charidimou; Lars-Olof Wahlund; Maria Kristofferson Wiberg; Sara Shams; Gloria Chia-Yi Chiang; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2015-10-19       Impact factor: 4.673

8.  High-fat diet alters prostanoid balance and perfusion in ischemic myocardium of naproxen-treated swine.

Authors:  Louis M Chu; Michael P Robich; Antonio D Lassaletta; Jun Feng; Shu Hua Xu; Robert Heinl; Yuhong Liu; Eric Sellke; Frank W Sellke
Journal:  Surgery       Date:  2011-09       Impact factor: 3.982

Review 9.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

10.  Thyroxine therapy ameliorates serum levels of eicosanoids in Chinese subclinical hypothyroidism patients.

Authors:  Yan Zhang; Bing-Chang Zhang; Jin Xu; Meng Zhao; Zhe Wang; Yong-Feng Song; Hai-Qing Zhang; Ling Gao; Qun-Ye Zhang; Jia-Jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2016-03-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.